Cancer Management and Research (Jul 2023)
ZFAS1 Promotes Cisplatin Resistance via Suppressing miR-421 Expression in Oral Squamous Cell Carcinoma [Retraction]
Abstract
Wang X, Hao R, Wang F, Wang F. Cancer Manag Res. 2020;12:7251–7262. We, the Editors and Publisher of Cancer Management and Research, have retracted the published article. Since publication, concerns have been raised about the integrity of the data in the article. This includes the duplication of images from figures within the article and with those from other articles. Specifically, The western blot bands in Figures 3K, CAL-27/DDP, Bax; SCC-9/DDP, BCL2 and 4C, CAL-27/DDP, β-actin, appear to have been duplicated with those from Figure 6A, Tca8113-CDDP, SF1; Figure 4G, Tca8113-CDDP, BCL2 and Figure 4H, TSCCA-CDDP, β-actin, respectively, from Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Cancer Med. 2017;6:2897–2908. https://doi.org/10.1002/cam4.1253 The western blot bands in Figure 3K, CAL-27/DDP, β-actin and SCC-9/DDP, β-actin appear to have been duplicated. When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
